The insulin receptor serves to focus the hormone on particular target tissues as well as to initiate the responses of these cells to the hormone. Extensive studies of the insulin receptor by many investigators have told us a great deal about this molecule, including its complete amino acid sequence as well as the role of specific residues in receptor function. In addition to binding insulin, the receptor has been shown to have an intrinsic tyrosine specific kinase activity. This activity is increased after the receptor binds insulin and appears to be critical for insulin to stimulate various biological responses. A reversible decrease in the receptor's intrinsic tyrosine kinase activity has been observed in cells from patients with non-insulin dependent diabetes, possibly contributing to the insulin resistance observed in these patients. In addition, a similar phenomena can be induced in cells in culture by stimulating the serine phosphorylation of the receptor with phorbol esters. In vitro, the receptor can be directly phosphorylated by a specific serine/threonine protein kinase, called protein kinase C. This phosphorylation also appears to decrease the intrinsic tyrosine kinase activity of the receptor without affecting the ability of the receptor to bind insulin. To further study the mechanisms of this regulation, we have identified one of the isozymes of protein kinase C for its ability to phosphorylate the receptor in vitro and have isolated stably transfected cell lines which overexpress the insulin receptor and this protein kinase C. We have found that the ability of insulin to activate the receptor kinase in these cells is inhibited ~ 70%. We therefore propose to further study this process by: 1) Selecting stable transfectants of this protein kinase C and various mutated insulin receptors to identify the specific sites regulated by this enzyme; 2) Test the affect of overexpression of kinase C on the ability of insulin and its receptor to be internalized and on insulin to induce various biological responses; 3) Test the specificity of this affect by isolating cell lines overexpressing the receptor and other protein kinase C isozymes and examining the same processes in these cells; and 4) Test whether insulin activates any of the protein kinase C isozymes. After responding to insulin, a cell must terminate its response. One mechanisms for accomplishing this is to degrade the hormone. One enzyme, called insulin-degrading enzyme, has been implicated in this process. We have produced monoclonal antibodies to this enzyme, and isolated a cDNA clone which codes for this molecule. We now propose to: 1) Identify residues in the active site of this protease by site-directed mutagenesis; 2) Increase and/or decrease the levels of this enzyme in cells to further test the role of this enzyme in terminating the response to insulin; and 3) Identify the regions of the protease involved in recognizing insulin by generating anti-peptide antibodies to specific sequences of the molecule. A further understanding of this enzyme may allow the design of specific inhibitors of insulin degradation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37DK034926-12
Application #
2139429
Study Section
Metabolism Study Section (MET)
Project Start
1984-07-01
Project End
1996-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Stanford University
Department
Biology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Kortylewski, Marcin; Feld, Florian; Kruger, Klaus-Dieter et al. (2003) Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism. J Biol Chem 278:5242-9
Faridi, Jesika; Fawcett, Janet; Wang, Lihong et al. (2003) Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradation. Am J Physiol Endocrinol Metab 285:E964-72
Wang, Lihong; Fraley, Cresson D; Faridi, Jesika et al. (2003) Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells. Proc Natl Acad Sci U S A 100:11249-54
Barthel, Andreas; Schmoll, Dieter; Kruger, Klaus-Dieter et al. (2002) Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 143:3183-6
Barthel, Andreas; Kruger, Klaus-Dieter; Roth, Richard A et al. (2002) Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes. Naunyn Schmiedebergs Arch Pharmacol 365:290-5
Barthel, A; Schmoll, D; Kruger, K D et al. (2001) Differential regulation of endogenous glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression by the forkhead transcription factor FKHR in H4IIE-hepatoma cells. Biochem Biophys Res Commun 285:897-902
Vainshtein, I; Kovacina, K S; Roth, R A (2001) The insulin receptor substrate (IRS)-1 pleckstrin homology domain functions in downstream signaling. J Biol Chem 276:8073-8
Iynedjian, P B; Roth, R A; Fleischmann, M et al. (2000) Activation of protein kinase B/cAkt in hepatocytes is sufficient for the induction of expression of the gene encoding glucokinase. Biochem J 351 Pt 3:621-7
Mirza, A M; Kohn, A D; Roth, R A et al. (2000) Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ 11:279-92
Nakatani, K; Sakaue, H; Thompson, D A et al. (1999) Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys Res Commun 257:906-10

Showing the most recent 10 out of 77 publications